Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Jarema

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Psychiatria Polska|December 22, 2015
Clinical determinants of mental disorders occurring during the infertility treatmentJustyna Holka-Pokorska, Marek Jarema, Adam Wichniak
Psychiatria Polska|May 16, 2009
[Antipsychotics in clinical practice. Treatment of the first schizophrenic episode]Marek Jarema, Joanna Meder, Aleksander Araszkiewicz, et al.
Psychiatria Polska|July 6, 2018
The controversy around the diagnosis of selective mutism - a critical analysis of three cases in the light of modern research and diagnostic criteriaJustyna Holka-Pokorska, Agnieszka Piróg-Balcerzak, Marek Jarema
Frontiers in Psychiatry|September 5, 2019
Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia-A Systematic ReviewEwa Tumiel, Adam Wichniak, Marek Jarema, et al.
Current Psychology (New Brunswick, N.J.)|March 23, 2018
Body Image and Body Experience Disturbances in Schizophrenia: an Attempt to Introduce the Concept of Body Self as a Conceptual FrameworkOlga Sakson-Obada, Paulina Chudzikiewicz, Daniel Pankowski, et al.
Psychiatria Polska|April 30, 2017
Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophreniaMarek Jarema, Przemysław Bieńkowski, Janusz Heitzman, et al.
Psychiatria Polska|June 22, 2015
[The stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patients with schizophrenia treated with olanzapine - a randomized, double-blind trial]Justyna Anna Holka-Pokorska, Rafał Radzio, Marek Jarema, et al.
Psychiatria Polska|May 16, 2009
[Antipsychotics in clinical practice. The refractory schizophrenic patients treatment]Joanna Meder, Magdalena Tyszkowska, Marek Jarema, et al.
Psychiatria Polska|August 2, 2002
[The change of quality of life and clinical picture in schizophrenia]Marek Jarema, Zuzanna Konieczyńska, Sławomir Murawiec, et al.
Neuropsychological Rehabilitation|May 2, 2017
Effects of cognitive remediation therapy versus other interventions on cognitive functioning in schizophrenia inpatientsMagdalena Linke, Konrad S Jankowski, Adam Wichniak, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Psychiatria Polska|December 22, 2015
Clinical determinants of mental disorders occurring during the infertility treatmentJustyna Holka-Pokorska, Marek Jarema, Adam Wichniak
Psychiatria Polska|May 16, 2009
[Antipsychotics in clinical practice. Treatment of the first schizophrenic episode]Marek Jarema, Joanna Meder, Aleksander Araszkiewicz, et al.
Psychiatria Polska|July 6, 2018
The controversy around the diagnosis of selective mutism - a critical analysis of three cases in the light of modern research and diagnostic criteriaJustyna Holka-Pokorska, Agnieszka Piróg-Balcerzak, Marek Jarema
Frontiers in Psychiatry|September 5, 2019
Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia-A Systematic ReviewEwa Tumiel, Adam Wichniak, Marek Jarema, et al.
Current Psychology (New Brunswick, N.J.)|March 23, 2018
Body Image and Body Experience Disturbances in Schizophrenia: an Attempt to Introduce the Concept of Body Self as a Conceptual FrameworkOlga Sakson-Obada, Paulina Chudzikiewicz, Daniel Pankowski, et al.
Psychiatria Polska|April 30, 2017
Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophreniaMarek Jarema, Przemysław Bieńkowski, Janusz Heitzman, et al.
Psychiatria Polska|June 22, 2015
[The stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patients with schizophrenia treated with olanzapine - a randomized, double-blind trial]Justyna Anna Holka-Pokorska, Rafał Radzio, Marek Jarema, et al.
Psychiatria Polska|May 16, 2009
[Antipsychotics in clinical practice. The refractory schizophrenic patients treatment]Joanna Meder, Magdalena Tyszkowska, Marek Jarema, et al.
Psychiatria Polska|August 2, 2002
[The change of quality of life and clinical picture in schizophrenia]Marek Jarema, Zuzanna Konieczyńska, Sławomir Murawiec, et al.
Neuropsychological Rehabilitation|May 2, 2017
Effects of cognitive remediation therapy versus other interventions on cognitive functioning in schizophrenia inpatientsMagdalena Linke, Konrad S Jankowski, Adam Wichniak, et al.
Pageof 6